Ellen Go, MD, Pediatric Rheumatologist, Riley Hospital for Children, Indianapolis, Indiana
2022 Vasculitis Pediatric Conference: Medications–What’s available for childhood vasculitis?

Introduction Dr. Ellen Go | 0:20 |
Drug discovery and development is a long and risky road. | 2:48 |
Facts about pediatric research. | 6:53 |
Programs to support pediatric drug development. | 7:54 |
Treatment considerations in childhood systemic vasculitis. | 8:45 |
What do these drugs have in common? | 10:02 |
Cyclophosphamide (low dose) | 10:57 |
Rituximab | 12:58 |
Steroids | 14:15 |
Methotrexate | 16:00 |
Azathioprine | 17:28 |
Tocilizumab | 18:36 |
Infliximab | 19:24 |
Mepolizumab | 21:02 |
Avocopan | 21:52 |
Takeaway tips. | 22:52 |
Ellen Go, MD, Pediatric Rheumatologist, Riley Hospital for Children, Indianapolis, Indiana
Building upon the collective strength of the vasculitis community, the Foundation supports, inspires and empowers individuals with vasculitis and their families through a wide range of education, research, clinical, and awareness initiatives.
The Vasculitis Foundation is a registered 501 (c) (3) non-profit organization. All contributions are 100% tax-deductible.
Click here to send us an email!
Mail:
Vasculitis Foundation
PO Box 28660
Kansas City, MO 64188
1.816.436.8211 or 1.800.277.9474
All Rights Reserved